4//SEC Filing
Prout Samantha 4
Accession 0000950170-24-001295
CIK 0001178879other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:30 PM ET
Size
9.9 KB
Accession
0000950170-24-001295
Insider Transaction Report
Form 4
Prout Samantha
Chief Accounting Officer
Transactions
- Award
Common Stock
2024-01-02+25,252→ 123,808 total - Award
Stock Options (right to buy)
2024-01-02+43,592→ 43,592 totalExercise: $14.24Exp: 2034-01-02→ Common Stock (43,592 underlying) - Tax Payment
Common Stock
2023-12-31$14.19/sh−23,356$331,422→ 98,556 total - Tax Payment
Common Stock
2024-01-02$14.24/sh−1,313$18,697→ 122,495 total
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 2, 2025 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001743122
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:30 PM ET
- Size
- 9.9 KB